AMBER GIESE: Open Payments
NPI 1790322873 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 56 payments from 18 companies in 2025. Trend: 2023 $15 · 2024 $443 · 2025 $1,155
Food & beverage: $1,136Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Lilly USA, LLC | 6 | $129 |
| Exact Sciences Corporation | 5 | $114 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Eisai Inc. | 3 | $80 |
| PFIZER INC. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| ABBVIE INC. | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
Products named: Ozempic, TRELEGY ELLIPTA, KISUNLA, Leqembi, AIRSUPRA, FARXIGA, The Cologuard Plus Collection Kit, LEQVIO.
Industry payments across FL — which companies pay providers there.
